Literature DB >> 12574552

Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.

Dwayne S G Conway1, Jan Heeringa, Deirdre A M Van Der Kuip, Bernard S P Chin, Albert Hofman, Jacqueline C M Witteman, Gregory Y H Lip.   

Abstract

BACKGROUND AND
PURPOSE: Atrial fibrillation (AF) is a major cause of stroke among the elderly. Evidence for a prothrombotic state in AF is controversial, and there is a lack of studies among the elderly. We studied the relationships between AF and 3 prothrombotic plasma markers-von Willebrand factor (vWf; a marker of endothelial damage/dysfunction), soluble P-selectin (sP-sel; a marker of platelet activation), and fibrinogen-in a matched case-control study nested within a large community-based study of an elderly population.
METHODS: We identified 162 elderly participants (mean+/-SD age, 78+/-8 years; 51% male) in the Rotterdam Study with documented AF and matched each case by age and sex to 2 population controls. vWf and sP-sel were measured by enzyme-linked immunosorbent assay; fibrinogen was measured with the Clauss method. We used conditional logistic regression analysis to assess the relationships between the markers and AF, adjusting for potential confounders.
RESULTS: There were no significant relationships between either fibrinogen (P=0.8) or sP-sel (P=0.6) and AF. However, a positive linear relationship between vWf level and presence of AF remained significant after adjustment for potential confounders among women (odds ratio [OR], 1.17; 95% CI, 1.02 to 1.34) per 10-IU/dL increase in vWf but not among men (OR, 1.06; 95% CI, 0.96 to 1.17).
CONCLUSIONS: We observed a positive relationship between AF and plasma vWf (or endothelial damage/dysfunction) in our elderly population, which was most apparent among women. Fibrinogen and sP-sel levels were unrelated to AF. The prothrombotic state of AF may be subject to sex differences, but longitudinal studies are needed to determine the relationship between these plasma markers and stroke risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574552     DOI: 10.1161/01.str.0000051728.85133.32

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation.

Authors:  Mónica Acevedo; Ramón Corbalán; Sandra Braun; Jaime Pereira; Ilse González; Carlos Navarrete
Journal:  J Thromb Thrombolysis       Date:  2012-02-03       Impact factor: 2.300

2.  Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Authors:  Margaret C Fang; Daniel E Singer; Yuchiao Chang; Elaine M Hylek; Lori E Henault; Nancy G Jensvold; Alan S Go
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

Review 3.  Role of inflammation in atrial fibrillation pathophysiology and management.

Authors:  Masahide Harada; David R Van Wagoner; Stanley Nattel
Journal:  Circ J       Date:  2015-02-16       Impact factor: 2.993

Review 4.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Authors:  Laila Staerk; Jason A Sherer; Darae Ko; Emelia J Benjamin; Robert H Helm
Journal:  Circ Res       Date:  2017-04-28       Impact factor: 17.367

5.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

Review 6.  New approaches to anticoagulation in atrial fibrillation.

Authors:  Palle Petersen
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 7.  Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.

Authors:  Gerardo Muñoz Cortés; Martha Eva Viveros Sandoval; Carlos Arturo Areán Martínez; Helios Eduardo Vega Gómez; Sandra Edith López Castañeda; Anel Gómez García
Journal:  J Atr Fibrillation       Date:  2014-12-31

8.  Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors:  Alan S Go; Margaret C Fang; Natalia Udaltsova; Yuchiao Chang; Niela K Pomernacki; Leila Borowsky; Daniel E Singer
Journal:  Circulation       Date:  2009-03-02       Impact factor: 29.690

9.  Can electronic tools help improve nursing home quality?

Authors:  Kjell Krüger; Line Strand; Jonn-Terje Geitung; Geir Egil Eide; Anders Grimsmo
Journal:  ISRN Nurs       Date:  2011-10-10

10.  Clinical study of isosorbide mononitrate treatment for angina pectoris in coronary heart disease.

Authors:  Zheng Tan; Xiaoming Shang; Li Li; Luobing Tian; Yi Ma; Yan Peng; Lingxi Gao
Journal:  Exp Ther Med       Date:  2013-02-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.